Exenatide sustained release - MidatechAlternative Names: Q-Exenatide
Latest Information Update: 13 Jul 2016
At a glance
- Originator Midatech
- Class Antihyperglycaemics; Obesity therapies; Peptides; Venoms
- Mechanism of Action Glucagon like peptide 1 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Type 2 diabetes mellitus
Most Recent Events
- 13 Jul 2016 Early research in Type-2 diabetes mellitus in United Kingdom (Parenteral)